"Teva Pharmaceutical Industries stock gained 0.8% on reports that it's considering the acquisition of rights to Zenvia, a chronic pain medication being developed by a company called Avanir Pharmaceuticals. Alternately, Teva might buy the whole company, lock, stock and barrel."